It was 17.6% before.
Please note that the Skin cancer and this latest trial are very important. Re the first one, I looked at some possible returns should it be successful and it seems to me there is big money involved.
We still have the skin ulcer trial as well of course and the trials with Ovarian cancer are continuing.
Gerry
